PARK7 enhances antioxidative‐stress processes of BMSCs via the ERK1/2 pathway

Abstract

Oxidative stresss in the microenvironment surrounding lesions induces apoptosis of transplanted bone-marrow-derived mesenchymal stem cells (BMSCs). Hence, there is an urgent need for improving antioxidative-stress processes of transplanted BMSCs to further promote their survival. The present study reports the role and mechanism of Parkinson's disease protein 7 (PARK7) in enhancing antioxidative activity in BMSCs. We used a PARK7 lentivirus to transfect BMSCs to up-or downregulate PARK7, and then used H 2 O 2 to simulate oxidative stress in BMSCs in vitro. Overexpression of PARK7 effectively reduced reactive oxygen species and malondialdehyde, protected mitochondrial membrane potential, and resisted oxidative-stress-induced apoptosis of BMSCs, but the expression of PARK7 was downregulated, these results were reversed. At the same time, we also found that overexpression of PARK7 increased extracellular-regulated protein kinase 1/2 (ERK1/2) phosphorylation and nuclear translocation, as well as upregulated Elk1 phosphorylation and superoxide dismutase (SOD) expression. In contrast, when U0126 was used to block the ERK1/2 pathway, ERK1/2 and Elk1 phosphorylation levels were downregulated, ERK1/2 nuclear translocation and SOD content were significantly reduced, and PARK7-overexperssion-induced antioxidative activity was completely blocked. Collectively, our results suggest that PARK7 overexpression increased antioxidative-stress processes and survival of BMSCs subjected to H 2 O 2 via activating the ERK1/2 signaling pathway. Our findings may guide the development of a PARK7-specific strategy for improving the transplantation efficacy of BMSCs. K E Y W O R D S bone-marrow-derived mesenchymal stem cells, extracellular-regulated protein kinase 1/2, oxidative stress, Parkinson's disease protein 7

Bone marrow mesenchymal stem cells in premature ovarian failure: Mechanisms and prospects

“…In addition, Parkinson’s disease protein 7 (PARK7) is an antioxidant protein that enhances cellular resistance to oxidative stress and stress-induced apoptosis ( 180 , 181 ). PARK7 overexpression enhances antioxidative‐stress capacity in BMSCs via activating the ERK1/2 signal pathway, which effectively decreases the level of ROS/malondialdehyde and protects the mitochondrial membrane potential as well as inhibits apoptosis of BMSCs subjected to oxidative stress ( 160 ). Moreover, PARK7 can also promote the disintegration of Nrf2/Kelch-like echinacoside associated protein 1 complex, thereby activating Nrf2.…”

Tocopherol attenuates the oxidative stress of BMSCs by inhibiting ferroptosis through the PI3k/AKT/mTOR pathway

“…Cyclosporin A had been shown to increase the viability of trophoblast cells and reduce the ROS-induced oxidative injury by the inhibition of the p38 pathway ( He et al, 2020 ). Overexpression of Parkinson’s disease protein 7 prevented the oxidative stress-induced apoptosis of transplanted BMSCs by the activation of the ERK1/2 pathway ( Zhang et al, 2021 ). Curcumin could attenuate oxidative stress and cardiomyocyte apoptosis to improve the cardiac function in streptozoticin-induced type 2 diabetic rats by the activation of the PI3K/AKT/mTOR pathway in vivo ( Ren et al, 2020 ).…”

CORM-3 Attenuates Oxidative Stress-Induced Bone Loss via the Nrf2/HO-1 Pathway

“…However, how CORM-3 ameliorates oxidative stress-induced damage is unclear. In the present study, oxidative stress was induced in BMSCs using H 2 O 2 as previously reported [ 21 ].…”